To identify fusions that were not detected in the CGMP panel, we selected 30 fusion-negative samples for RNAseq (data not shown), and found that no fusions were detected in 29 cases, but a novel FMNL3-LRRK2 fusion was identified in the intimal sarcoma sample, AF0048. This evidence concerns the gene LRRK2 and sarcoma.